Identifying the drawbacks of joint patents: An evaluation of IPR sharing in R&D alliances in Biotechnology Firms in Singapore

Journal of commercial biotechnology Pub Date : 2023-02-02 DOI:10.5912/jcb1528

Dr. Muhammad Haseeb, Dr. Nira Hariyatie Hartani

{"title":"Identifying the drawbacks of joint patents: An evaluation of IPR sharing in R&D alliances in Biotechnology Firms in Singapore","authors":"Dr. Muhammad Haseeb, Dr. Nira Hariyatie Hartani","doi":"10.5912/jcb1528","DOIUrl":null,"url":null,"abstract":"R&D alliances in the biotechnology industry have always been common in order to fulfill the demands and needs of the involved parties to carry out their innovation processes. The increasing trend of R&D alliances in the biotechnology industry in Singapore has also promoted IPR sharing in R&D alliances. This mechanism has promoted the concept of joint patents in this regard. Thus, the present study focused on the drawbacks of joint patents in R&D alliances in biotech firms in Singapore. For this purpose, semi-structured interviews were conducted with five employers from different biotech firms in Singapore. The collected data was then analyzed using NVivo software, and project map and tree maps were formulated for each research objective. The results obtained from this study showed that R&D alliances are effective in improving the financial and innovation performance of biotechnology firms. It has also been observed that IPR sharing in these alliances is effective in promoting technology and knowledge transfer. However, various drawbacks of joint patents were also observed, including financial issues, technology-related issues, and legal issues.","PeriodicalId":88541,"journal":{"name":"Journal of commercial biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of commercial biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5912/jcb1528","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

R&D alliances in the biotechnology industry have always been common in order to fulfill the demands and needs of the involved parties to carry out their innovation processes. The increasing trend of R&D alliances in the biotechnology industry in Singapore has also promoted IPR sharing in R&D alliances. This mechanism has promoted the concept of joint patents in this regard. Thus, the present study focused on the drawbacks of joint patents in R&D alliances in biotech firms in Singapore. For this purpose, semi-structured interviews were conducted with five employers from different biotech firms in Singapore. The collected data was then analyzed using NVivo software, and project map and tree maps were formulated for each research objective. The results obtained from this study showed that R&D alliances are effective in improving the financial and innovation performance of biotechnology firms. It has also been observed that IPR sharing in these alliances is effective in promoting technology and knowledge transfer. However, various drawbacks of joint patents were also observed, including financial issues, technology-related issues, and legal issues.

查看原文本刊更多论文

联合专利的弊端:对新加坡生物技术公司研发联盟中知识产权共享的评价

在生物技术产业中，为了满足相关方的创新需求，研发联盟一直是常见的。新加坡生物技术产业研发联盟的增加趋势也促进了研发联盟的知识产权共享。这一机制在这方面促进了共同专利的概念。因此，本研究聚焦于新加坡生物技术公司研发联盟中联合专利的弊端。为此，我们对来自新加坡不同生物技术公司的五位雇主进行了半结构化访谈。然后使用NVivo软件对收集到的数据进行分析，并为每个研究目标制定项目图和树状图。研究结果表明，研发联盟对生物技术企业的财务绩效和创新绩效有显著的提升作用。人们还观察到，在这些联盟中分享知识产权对促进技术和知识转移有效。然而，联合专利的各种弊端也被观察到，包括财务问题、技术相关问题和法律问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of commercial biotechnology

CiteScore

1.20

自引率

0.00%

发文量